These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30253992)

  • 41. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
    Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
    J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebellar glioblastoma multiforme in an adult woman.
    Sciacero P; Girelli GF; Cante D; Franco P; Casanova Borca V; Grosso P; Marra A; Bombaci S; Tofani S; La Porta MR; Ricardi U
    Tumori; 2014; 100(3):e74-8. PubMed ID: 25076255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy.
    Bronnimann C; Izquierdo C; Cartalat S; Thomas L; Joubert B; Delpech L; Barritault M; Meyronet D; Honnorat J; Ducray F
    J Neurooncol; 2018 May; 138(1):141-145. PubMed ID: 29388033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.
    Mistry AM; Vnencak-Jones CL; Mobley BC
    J Neurooncol; 2018 Jun; 138(2):307-313. PubMed ID: 29423539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of glioblastoma: State of the art and future directions.
    Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
    CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The evolution of the EGFRvIII (rindopepimut) immunotherapy for glioblastoma multiforme patients.
    Paff M; Alexandru-Abrams D; Hsu FP; Bota DA
    Hum Vaccin Immunother; 2014; 10(11):3322-31. PubMed ID: 25625931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary Focal Intracranial Leptomeningeal Glioma: Case Report and Review of the Literature.
    Narayan V; Savardekar A; Mohammed N; Patra DP; Georgescu MM; Nanda A
    World Neurosurg; 2018 Aug; 116():163-168. PubMed ID: 29689399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literature.
    Hintenlang LL; Miller DH; Kaleem T; Patel N; May BC; Tzou KS; Vallow LA; Buskirk SJ; Miller RC; Ko SJ; Jaeckle KA; Trifiletti DM; Peterson JL
    J Clin Neurosci; 2018 Feb; 48():118-121. PubMed ID: 29183682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Symptomatic leptomeningeal and intramedullary metastases from intracranial glioblastoma multiforme: a case report.
    Scoccianti S; Detti B; Meattini I; Iannalfi A; Sardaro A; Leonulli BG; Martinelli F; Bordi L; Pellicanò G; Biti G
    Tumori; 2008; 94(6):877-81. PubMed ID: 19267111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FDG PET/CT in Recurrent Glioblastoma Multiforme With Leptomeningeal and Diffuse Spinal Cord Metastasis.
    Malik D
    Clin Nucl Med; 2021 Feb; 46(2):138-139. PubMed ID: 33234937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma.
    Ishikawa E; Muragaki Y; Yamamoto T; Maruyama T; Tsuboi K; Ikuta S; Hashimoto K; Uemae Y; Ishihara T; Matsuda M; Matsutani M; Karasawa K; Nakazato Y; Abe T; Ohno T; Matsumura A
    J Neurosurg; 2014 Sep; 121(3):543-53. PubMed ID: 24995786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
    Gramatzki D; Kickingereder P; Hentschel B; Felsberg J; Herrlinger U; Schackert G; Tonn JC; Westphal M; Sabel M; Schlegel U; Wick W; Pietsch T; Reifenberger G; Loeffler M; Bendszus M; Weller M
    Neurology; 2017 Apr; 88(15):1422-1430. PubMed ID: 28298550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
    Suchorska B; Jansen NL; Linn J; Kretzschmar H; Janssen H; Eigenbrod S; Simon M; Pöpperl G; Kreth FW; la Fougere C; Weller M; Tonn JC;
    Neurology; 2015 Feb; 84(7):710-9. PubMed ID: 25609769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab.
    Papageorgiou GI; Tsakatikas SA; Fioretzaki RG; Kosmas C
    Anticancer Drugs; 2021 Mar; 32(3):330-336. PubMed ID: 33229903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple bone metastases from glioblastoma multiforme without local brain relapse: a case report and review of the literature.
    Takanen S; Bangrazi C; Caiazzo R; Raffetto N; Tombolini V
    Tumori; 2013; 99(5):e237-40. PubMed ID: 24362877
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spinal glioblastoma multiforme of the conus medullaris with holocordal and intracranial spread in a child: a case report and review of the literature.
    Mori K; Imai S; Shimizu J; Taga T; Ishida M; Matsusue Y
    Spine J; 2012 Jan; 12(1):e1-6. PubMed ID: 22197783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advantages and Disadvantages of Combined Chemotherapy with Carmustine Wafer and Bevacizumab in Patients with Newly Diagnosed Glioblastoma: A Single-Institutional Experience.
    Akiyama Y; Kimura Y; Enatsu R; Mikami T; Wanibuchi M; Mikuni N
    World Neurosurg; 2018 May; 113():e508-e514. PubMed ID: 29476996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Spinal leptomeningeal metastasis from cerebral glioblastoma: case report].
    Toledano Delgado R; Garcia N; Riva-Amarante E; Rodríguez Pascual J; García Leal R; Sendra Tello J
    Neurologia; 2006 Sep; 21(7):378-81. PubMed ID: 16977559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of Glioma Stemlike Cell Infiltration in the Non-Contrast-Enhancing Area by Quantitative Measurement of Lactate on Magnetic Resonance Spectroscopy in Glioblastoma.
    Inoue A; Nishikawa M; Ohnishi T; Yano H; Kanemura Y; Ohtsuka Y; Ozaki S; Nakamura Y; Matsumoto S; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
    World Neurosurg; 2021 Sep; 153():e76-e95. PubMed ID: 34144167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.